Hisun Pharmaceutical (Hangzhou) Co., Ltd.

FDA inspection history in Hangzhou, China, 2016 to 2021

2
Form 483s

Every document, by year

  • Form 483

2016: one Form 483; 2021: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2016One Form 483, at Hangzhou, China.
  2. 2016The longest 483 on file: 12 observations over 10 pages at Hangzhou, China.
  3. 2021One Form 483, at Hangzhou, China.

Cited most

Across all Hisun Pharmaceutical (Hangzhou) Co. observations on file

The complete Hisun Pharmaceutical (Hangzhou) Co. file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2021-07-20483 Form 483$99
2016-10-27483 Form 483$99

FEI number 3008481334 · most recent document Jul 20, 2021

About Hisun Pharmaceutical (Hangzhou) Co., Ltd.

How many FDA Form 483s has Hisun Pharmaceutical (Hangzhou) Co., Ltd. received?

FDA Intel has 2 Form 483s on file for Hisun Pharmaceutical (Hangzhou) Co., Ltd.; the most recent is dated Jul 20, 2021.

When was Hisun Pharmaceutical (Hangzhou) Co., Ltd. last inspected by FDA?

The most recent FDA inspection document on file for Hisun Pharmaceutical (Hangzhou) Co., Ltd. is a Form 483 dated Jul 20, 2021, for the site in Hangzhou, China.

What did FDA cite at Hisun Pharmaceutical (Hangzhou) Co., Ltd.?

The regulations cited most in the observations on file for Hisun Pharmaceutical (Hangzhou) Co., Ltd. are 21 CFR 211.100 (Written procedures; deviations), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.160 (General requirements), 2 times.